-
Waitlisted for Lung Transplant and the Role of Patient Travel Distance: A National Cohort Study
-
What Are Factors That Can Influence The High Immunological Graft Loss Rate In Young Pancreas Transplant Recipients
-
What Are You Smoking? The Impact of Donor Drug Use on Long Term Survival Post-Transplant
-
What Do We Not Know about Long Term Liver Transplant Patients? A Look at Side Effect Burden and Medication Adherence
-
What is the Post-Heart Transplant Risk of Infectious Complications from Pre-Transplant Desensitization Therapy?
-
What’s in a High Dose? An Analysis of Tacrolimus Pharmacokinetic Parameters in Rapid Metabolizers
-
When to Hold: Apixaban in Renal Transplant Recipients
-
When to Transplant for Wilson’s Disease: A Review
-
Whole Body CT Imaging in Deceased Donor Screening
-
Whole-Exome Sequencing Identifies PMS1 and DYRK1A Genes Contributing to Occurrence of Liver Cancer
-
Wide Geographic Variability in the Proportion of Donors with Cardiac Death – Lost Opportunities for Organ Donation?
-
Willingness to Acquire Donor-Derived Hepatitis C Infection May Reduce Waitlist Mortality for Heart Transplant Candidates
-
Withaferin A as a Possible Therapy for Chronic Allograft Nephropathy
-
Withaferin A Shifts Circulating Lymphocytes toward Protective T Cell Subsets and Prolongs Islet Allograft Survival in a Mouse Transplant Model
-
Women Who Undergo Liver Transplant Have Increased Health Care Utilization in the Peri-Transplant Period Compared with Men
2019 American Transplant Congress
June 1-5, 2019 in Boston, MA